Leadership perspectives: Challenges in biomedical science and workforce planning
30 Sept 2024
In this insightful discussion, David Wells, CEO of the Institute of Biomedical Science (IBMS), in discussion with Sonia Nicholas, Managing Editor of SelectScience, highlights the critical role of biomedical scientists in healthcare, noting their involvement in 70-95% of patient pathways. Wells addresses challenges such as rising diagnostic costs, workforce shortages, and the need for strategic use of diagnostics. Wells emphasizes the importance of utilizing biomedical scientists to their full potential and the need for innovative solutions, including automation and global collaboration. This conversation, part of the #CLINICAL24 discussion, sheds light on the evolving landscape of healthcare, the essential contributions of biomedical science and the need for the IBMS Long Term Workforce Plan.
This interview was recorded for #CLINICAL24 2024
About the company
Institute of Biomedical Sciences (IBMS)
The Institute of Biomedical Science (IBMS) is the professional body for biomedical scientists in the United Kingdom.
The Institute aims to promote and develop the role of biomedical science within healthcare to deliver the best possible service for patient care and safety. It does this by supporting biomedical scientists in their education and training, improving standards of practice, representing the profession and working with organisations to improve laboratory service.
